Company
ASX:CUV
Melanocortin photomedicine (tissue resilience).
Thesis
Market data
| Metric | Detail |
|---|---|
| Exchange | ASX |
| Ticker | ASX:CUV |
| Secondary listing | None |
| Market cap | ~A$360M |
| Status | Listed and trading |
Get in touch
Offering
No commercial services are recorded for this company yet.
People
variis does not publish portraits of named individuals without a licence to do so.
Recent inflection
CUV105 Ph3 vitiligo enrolled; results H2 2026.
Keep reading
Sources
No source is on file for this company yet. Treat everything above as unverified until one is.
Every entity profile on variis is sourced. Not investment advice.